<ѻýҕl>Want a Few Weeks of Knee Pain Relief? Try Thisѻýҕl> Local nerve block proves mettle in randomized trial, though benefit didn't last long Nov 12, 2022
<ѻýҕl>Chronic Pain: Opioids No Longer Treatment of Choiceѻýҕl> Nondrug therapies increased markedly in wake of 2016 CDC guidance Nov 07, 2022
<ѻýҕl>New ACR/EULAR Guideline Expands RA Remission Definitionѻýҕl> Axial spondyloarthritis guidance also gets an update Oct 25, 2022
<ѻýҕl>Does Rheumatoid Arthritis Get Its Start in the Gut?ѻýҕl> Patients and at-risk individuals show antibodies to common intestinal bacterium Oct 20, 2022
<ѻýҕl>Is PMR the Next Indication for Tocilizumab?ѻýҕl> Phase III data suggest yes, albeit in a limited population and with several cautions Sep 20, 2022
<ѻýҕl>Predicting Fractures in RA: Is FRAX Useful in the Modern Treatment Era?ѻýҕl> Algorithm held its own, but not many study patients were on biologics Sep 11, 2022
<ѻýҕl>Pirfenidone Shows Hints of Benefit for RA-Related Lung Diseaseѻýҕl> But early halt to recruitment, forced by pandemic, left trial underpowered Sep 06, 2022
<ѻýҕl>Novel IL-6 Blocker Matches Humira in Rheumatoid Arthritisѻýҕl> But is Russian backing a problem for U.S. approval? Aug 24, 2022
<ѻýҕl>More Bad Safety News for Xeljanzѻýҕl> Yet another risk confirmed in postmarketing study Aug 04, 2022
<ѻýҕl>Lubricant Shots for Knee OA: No, They Really Don't Helpѻýҕl> Meta-analysis of hyaluronic acid trials throws serious shade on common practice Jul 06, 2022
<ѻýҕl>Novel Anti-TNF Shines in Rheumatoid Arthritis Trialѻýҕl> Trivalent "nanobody" biologic engineered to accumulate in inflamed tissue Jun 24, 2022
<ѻýҕl>Guideline: Timing Is Everything for RA and Lupus Patients Needing Joint Replacementѻýҕl> New advice on which antirheumatic meds to continue and which to stop before surgery Jun 21, 2022
<ѻýҕl>Novel IL-17 Inhibitor Passes Mid-Stage Test in Psoriatic Arthritisѻýҕl> Phase II results suggest drug could outperform existing agents Jun 03, 2022
<ѻýҕl>Trial Upends Guidelines on Long-Term Steroids in Rheumatoid Arthritisѻýҕl> Vindication for clinicians who ignored official recommendations Jun 03, 2022
<ѻýҕl>Air Pollution and Illness: It's Not Just the Lungs and Heart Anymoreѻýҕl> Expanding range of conditions caused or aggravated by fine particulates Jun 01, 2022
<ѻýҕl>Is Alzheimer's Risk Lower With TNF Inhibitors?ѻýҕl> For arthritis patients with cardiovascular disease, the answer may be yes Apr 08, 2022
<ѻýҕl>'It's an Alien Knee in There': Mixed Feelings After Joint Replacementѻýҕl> Study highlights common, but rarely discussed, problem Mar 28, 2022
<ѻýҕl>Glaucoma: The Newest Autoimmune Disease?ѻýҕl> Researchers argue for a "paradigm shift" Mar 21, 2022
<ѻýҕl>Reassurance on Steroid Shots for Knee OAѻýҕl> Study counters fears that injections worsen underlying pathology Mar 17, 2022
<ѻýҕl>Ankylosing Spondylitis: Another Step Toward Individualized Therapyѻýҕl> Study IDs factors predicting response to TNF inhibitors Mar 15, 2022
<ѻýҕl>Hopes Dashed for Novel Osteoarthritis Treatmentѻýҕl> Noninvasive therapy looked like a sure winner until trial results came in Mar 08, 2022
<ѻýҕl>Two Years On, Tremfya Still Shines in Psoriatic Arthritisѻýҕl> Efficacy increases in long-term extension data Feb 10, 2022
<ѻýҕl>Mystery: Why Would Hand OA Be Less Severe in Black People?ѻýҕl> Data contrast with previous findings for hip and knee osteoarthritis Feb 04, 2022
<ѻýҕl>Trial Data Confirm Heightened Risks With JAK Inhibitorѻýҕl> May help patients and clinicians better weigh benefit against adverse effects Jan 26, 2022
<ѻýҕl>Muddled Picture for Antidepressant as Osteoarthritis Pain Relieverѻýҕl> Trial in primary care setting fails to confirm benefit seen in specialty clinics Jan 06, 2022
<ѻýҕl>Another Trial, Another PRP Flop in Osteoarthritisѻýҕl> Fails to outperform saline in randomized trial Nov 23, 2021
<ѻýҕl>Another Study Confirms Gout Benefit With SGLT2 Inhibitorsѻýҕl> Gout risk reduction was significantly better than with DPP-4 inhibitors Nov 19, 2021
<ѻýҕl>Biologic Disappoints for Arthritis Achilles' Inflammationѻýҕl> But phase III trial did find some patient-oriented benefits Nov 11, 2021
<ѻýҕl>Vitamin D and Disease Prevention: Worth Another Look?ѻýҕl> Incidence of autoimmune disease decreased by 25-30% with dietary supplements Nov 08, 2021
<ѻýҕl>Early Biologics Better in Juvenile Idiopathic Arthritisѻýҕl> After 2 years, more patients on combo biologic/DMARD regimen had inactive disease Nov 08, 2021
<ѻýҕl>No Love for PRP in Ankle Osteoarthritis Trialѻýҕl> Dutch researchers throw cold water on popular therapy Oct 26, 2021
<ѻýҕl>How Should Patients With Autoimmune Diseases Approach COVID Vaccination?ѻýҕl> Mixed messaging and a lack of tailored research leaves providers and patients in the dark Oct 22, 2021
<ѻýҕl>First Interchangeable Humira Biosimilar Approvedѻýҕl> Cyltezo nabs coveted "interchangeable" status for RA, inflammatory bowel disease, and more Oct 18, 2021
<ѻýҕl>In RA, Little Risk for Recurrent Cancer With Biologic Treatmentѻýҕl> Results important because most trials excluded patients with previous cancer, researchers note Sep 23, 2021
<ѻýҕl>Statins Not Linked With Rheumatoid Arthritis, Large Study Findsѻýҕl> Risks attenuated after adjustment for lipid levels Sep 22, 2021
<ѻýҕl>Lymphoma in RA: Disease Activity Mattersѻýҕl> Strongest risk factors were baseline disease activity scores and bone erosions Sep 08, 2021
<ѻýҕl>FDA Slaps Restrictions on JAK Inhibitors Over Serious Safety Risksѻýҕl> Use for inflammatory conditions limited to those who fail on TNF blockers Sep 01, 2021
<ѻýҕl>New-Onset IBD and IL-17 Inhibitors: What Is the Risk?ѻýҕl> Underlying inflammatory disease severity should be taken into account Jul 21, 2021